The Chinese National Medical Products Administration (NMPA) officially accepted this application on 21 August 2023, with an anticipated market launch in mid-June 2024
Compounded GLP-1 medications are not substitutes for prescribed medical treatment by a clinician familiar with your personal health history
Most practitioners recommend continuing at a lower maintenance dose to prevent weight regain
That means your results depend on factors like taking the medication consistently, reaching the right dose with your healthcare provider, and maintaining healthy lifestyle habitsnot on whether you chose your stomach instead of your thigh
Commonly recognized side effects, such as gastrointestinal symptoms, were also widely reported, lending credibility to the approach
For most patients, side effects are manageable and temporary